Patents by Inventor Alan Hendrick

Alan Hendrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of the receptor GPR86
    Patent number: 7879564
    Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: February 1, 2011
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Nicola Brice, Mark Carlton, John Dixon, Alan Hendrick, Isabelle Malinge, Sophie Messager, Dirk Zahn
  • Use of GPR100 Receptor in Diabetes and Obesity Regulation
    Publication number: 20100311077
    Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, the method comprising determining whether a candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which the Gpr100 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5, or a sequence which is at least 90% identical thereto.
    Type: Application
    Filed: March 16, 2010
    Publication date: December 9, 2010
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Samuel Aparicio, John Dixon, Alan Hendrick, Jennifer M. Horwood, Dirk Zahn
  • GPR 26 G-Protein Coupled Receptor
    Publication number: 20090048200
    Abstract: We disclose GPR26 G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO. 3 or SEQ ID NO: 5, and homologues, variants and derivatives thereof. Nucleic acids capable of encoding GPR26 polypeptide are also disclosed. The GPR26 receptor is useful in the diagnosis and therapy of mental illness.
    Type: Application
    Filed: October 30, 2006
    Publication date: February 19, 2009
    Inventors: Alan Hendrick, John Dixon, Tere Michelle Tait, Rosa Fradley, Malcolm Sheardown, Haiping Liu, Kok Siu Foo
  • Use of Gpr100 receptor in diabetes and obesity regulation
    Publication number: 20080269118
    Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, the method comprising determining whether a candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which the Gpr100 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5, or a sequence which is at least 90% identical thereto.
    Type: Application
    Filed: December 21, 2006
    Publication date: October 30, 2008
    Inventors: Samuel Aparicio, John Dixon, Alan Hendrick, Jennifer Marie Horwood, Dirk Zahn
  • Use of the receptor GPR86
    Publication number: 20070248545
    Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.
    Type: Application
    Filed: December 21, 2006
    Publication date: October 25, 2007
    Inventors: Nicola Brice, Mark Carlton, John Dixon, Alan Hendrick, Isabelle Malinge, Sophie Messager, Dirk Zahn
  • Receptor
    Publication number: 20060242724
    Abstract: The present invention relates to novel functions of a known receptor. In particular, the invention relates to the use of a sphingosylphosphorylcholine receptor and/or ligands thereof in the manipulation of the neuronal and limbic systems and diagnosis and treatment of pain.
    Type: Application
    Filed: March 20, 2006
    Publication date: October 26, 2006
    Inventors: Mark Carlton, John Dixon, Alan Hendrick, Sophie Messager, Dirk Zahn, Jennifer Horwood
  • GPR54 knock-out mammals and screening methods using them
    Publication number: 20060015954
    Abstract: The present invention relates to novel functions of a known receptor. In particular, the invention relates to the use of a galanin-like receptor and/or ligands thereof in the manipulation of the pituitary hormonal axis and reproductive systems.
    Type: Application
    Filed: April 25, 2005
    Publication date: January 19, 2006
    Inventors: Samuel Aparicio, William Colledge, John Dixon, Alan Hendrick, Sophie Messager, Rosemary Thresher, Dirk Zahn